Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Immunogenicity and Safety of Yellow Fever Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients After Withdrawal of Immunosuppressive Therapy.

Sicre de Fontbrune F, Arnaud C, Cheminant M, Boulay A, Konopacki J, Lapusan S, Robin C, Bernaudin F, Suarez F, Simon F, Socié G, Colin de Verdière N, Consigny PH.

J Infect Dis. 2018 Jan 17;217(3):494-497. doi: 10.1093/infdis/jix564.

PMID:
29087520
2.

Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.

Tron L, Lert F, Spire B, Dray-Spira R; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)‐Vespa2 Study Group.

HIV Med. 2017 Mar;18(3):181-195. doi: 10.1111/hiv.12412. Epub 2016 Jul 6.

PMID:
28967199
3.

Simple Scoring System to Predict In-Hospital Mortality After Surgery for Infective Endocarditis.

Gatti G, Perrotti A, Obadia JF, Duval X, Iung B, Alla F, Chirouze C, Selton-Suty C, Hoen B, Sinagra G, Delahaye F, Tattevin P, Le Moing V, Pappalardo A, Chocron S; Association for the Study and Prevention of Infective Endocarditis Study Group–Association pour l'Étude et la Prévention de l'Endocadite Infectieuse (AEPEI).

J Am Heart Assoc. 2017 Jul 20;6(7). pii: e004806. doi: 10.1161/JAHA.116.004806.

4.

Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype.

Mercier-Delarue S, Durier C, Colin de Verdière N, Poveda JD, Meiffrédy V, Fernandez Garcia MD, Lastère S, Césaire R, Manuggera JC, Molina JM, Amara A, Simon F.

PLoS One. 2017 May 31;12(5):e0177882. doi: 10.1371/journal.pone.0177882. eCollection 2017.

5.

Prevalence of and factors associated with depression among people living with HIV in France.

Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R; Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS)-VIH: Enquête sur les personnes atteintes (Vespa2) Study Group.

HIV Med. 2017 Jul;18(6):383-394. doi: 10.1111/hiv.12438. Epub 2016 Sep 14.

PMID:
27625202
6.

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, Launay O, Pialoux G, Slim J, Weiss L, Bouchaud O, Felizarta F, Meurer A, Raffi F, Esser S, Katlama C, Koletar SL, Mounzer K, Swindells S, Baxter JD, Schneider S, Chas J, Molina JM, Koutsoukos M, Collard A, Bourguignon P, Roman F.

Medicine (Baltimore). 2016 Feb;95(6):e2673. doi: 10.1097/MD.0000000000002673.

7.

Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.

Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R; PARCOURS Study Group.

AIDS. 2016 Feb 20;30(4):645-56. doi: 10.1097/QAD.0000000000000957.

8.

Molecular characterization of the 17D-204 yellow fever vaccine.

Salmona M, Gazaigne S, Mercier-Delarue S, Garnier F, Korimbocus J, Colin de Verdière N, LeGoff J, Roques P, Simon F.

Vaccine. 2015 Oct 5;33(41):5432-6. doi: 10.1016/j.vaccine.2015.08.055. Epub 2015 Aug 24.

PMID:
26314624
9.

Has the employment status of people living with HIV changed since the early 2000s?

Annequin M, Lert F, Spire B, Dray-Spira R; VESPA2 Study Group.

AIDS. 2015 Jul 31;29(12):1537-47. doi: 10.1097/QAD.0000000000000722.

PMID:
26244393
10.

Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.

Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B; OPTIPRIM ANRS-147 Study Group.

J Antimicrob Chemother. 2015 Jul;70(7):2108-20. doi: 10.1093/jac/dkv084. Epub 2015 Apr 21.

PMID:
25900157
11.

Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).

Douab T, Marcellin F, Vilotitch A, Protopopescu C, Préau M, Suzan-Monti M, Sagaon-Teyssier L, Lert F, Carrieri MP, Dray-Spira R, Spire B; ANRS-VESPA2 Study Group.

AIDS Care. 2014;26 Suppl 1:S29-40. doi: 10.1080/09540121.2014.906553. Epub 2014 Apr 14.

PMID:
24731158
12.

Prognostic value of skin manifestations of infective endocarditis.

Servy A, Valeyrie-Allanore L, Alla F, Lechiche C, Nazeyrollas P, Chidiac C, Hoen B, Chosidow O, Duval X; Association Pour l'Etude et la Prévention de l'Endocardite Infectieuse Study Group.

JAMA Dermatol. 2014 May;150(5):494-500.

PMID:
24500311
13.

Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.

Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O; Vihvo Study Group.

HIV Clin Trials. 2013 Nov-Dec;14(6):313-8. doi: 10.1310/hct1406-313.

PMID:
24334184
14.

Travelers with cutaneous leishmaniasis cured without systemic therapy.

Morizot G, Kendjo E, Mouri O, Thellier M, Pérignon A, Foulet F, Cordoliani F, Bourrat E, Laffitte E, Alcaraz I, Bodak N, Ravel C, Vray M, Grogl M, Mazier D, Caumes E, Lachaud L, Buffet PA; Cutaneous Leishmaniasis French Study Group.

Clin Infect Dis. 2013 Aug;57(3):370-80. doi: 10.1093/cid/cit269. Epub 2013 Apr 30.

PMID:
23633111
15.

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).

Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P; S 130 Apollo Trial Group.

Antimicrob Agents Chemother. 2013 Feb;57(2):758-65. doi: 10.1128/AAC.01662-12. Epub 2012 Nov 19.

16.

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.

Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D; ANRS 130 APOLLO Trial Study Group.

J Antimicrob Chemother. 2013 Mar;68(3):690-6. doi: 10.1093/jac/dks455. Epub 2012 Nov 14.

PMID:
23152480
17.

Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey.

Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B; AEPEI Study Group.

Clin Infect Dis. 2012 May;54(9):1230-9. doi: 10.1093/cid/cis199.

PMID:
22492317
18.

Tickborne relapsing fever caused by Borrelia persica, Uzbekistan and Tajikistan.

Colin de Verdiere N, Hamane S, Assous MV, Sertour N, Ferquel E, Cornet M.

Emerg Infect Dis. 2011 Jul;17(7):1325-7. doi: 10.3201/eid1707.101894. No abstract available.

19.

Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial.

Launay O, Desaint C, Durier C, Loulergue P, Duval X, Jacomet C, Pialoux G, Ghosn J, Raffi F, Rey D, Ajana F, Colin de Verdière N, Reynes J, Foubert V, Roman F, Devaster JM, Delfraissy JF, Aboulker JP; ANRS 151 HIFLUVAC Study Group and the French Clinical Vaccinology Network (Réseau National d'Investigation Clinique en Vaccinologie REIVAC).

J Infect Dis. 2011 Jul 1;204(1):124-34. doi: 10.1093/infdis/jir211.

20.

Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.

Launay O, van der Vliet D, Rosenberg AR, Michel ML, Piroth L, Rey D, Colin de Verdière N, Slama L, Martin K, Lortholary O, Carrat F; ANRS HB03 VIHVAC-B Trial.

JAMA. 2011 Apr 13;305(14):1432-40. doi: 10.1001/jama.2011.351.

PMID:
21486976

Supplemental Content

Loading ...
Support Center